Microwave-assisted synthesis of new fluorinated coumarin-pyrimidine hybrids as potent anticancer agents, their DNA cleavage and X-ray crystal studies

RSC Advances

Volumn 5, Issue 15, 2015, Pages 11261-11271

  Hosamani, Kallappa M ^a   Reddy, Dinesh S ^a   Devarajegowda, Hirihalli C ^b  

^a KARNATAK UNIVERSITY   (India)

^b UNIVERSITY OF MYSORE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CRYSTAL STRUCTURE; CYTOLOGY; DISEASES; DNA; ELECTROPHORESIS; MICROWAVE IRRADIATION; PLATINUM COMPOUNDS; SINGLE CRYSTALS; SPECTROSCOPIC ANALYSIS; X RAY DIFFRACTION;

ANTI-CANCER AGENTS; ANTICANCER ACTIVITIES; GEL ELECTROPHORESIS; HUMAN ADENOCARCINOMA; HUMAN CANCER CELLS; MICROWAVE ASSISTED SYNTHESIS; PATHOGENIC ORGANISMS; SINGLE CRYSTAL X-RAY DIFFRACTION;

CELLS;

EID: 84921894411     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c4ra12222d     Document Type: Article

References (67)

1. P. Anand, A. B. Kunnumakkara, C. Sundaram, K. B. Harikumar, S. T. Tharakan, O. S. Lai, B. Sung and B. B. Aggarwal, Pharm. Res., 2008, 25, 2097-2116.
2. S. K. Arya and S. Bhansali, Lung cancer and its early detection using biomarker-based biosensors, Chem. Rev., 2011, 111, 6783-6809.
3. World Cancer Report, International Agency for Research on Cancer, 2008, accessed 27 December 2012, http://www.iarc.fr/en/publications/pdfs-online/wcr/.
4. (a) I. Caleta, M. Krali, M. Marjanovic, B. Bertosa, S. Tomic, G. Pavilovic, K. Pavelic and G. Karminski-Zamola, J. Med. Chem., 2009, 52, 1744-1756;
5. (b) E. B. Lindgren, M. A. de Brito, T. R. A. Vasconcelos, M. O. de Moraes, R. C. Montenegro, J. D. Yoneda and K. Z. Leal, Eur. J. Med. Chem., 2014, 86, 12-16.
6. E. Borowski, M. M. Bontemps-Gracz and A. Piwkowska, Acta Biochim. Pol., 2005, 52, 609-627.
7. (a) H. Zhang, Y. Li and Z.-X. Jiang, Biomol. Res. Ther., 2012, 1, 1000-1007;
8. (b) A. J. Elliott, in Chemistry of Organic Fluorine Compounds. II. A Critical Review, ACS Monograph 187, ed. M. Hudlicky and A. E. Pavlath, American Chemical Society, Washington, DC, 1995, pp. 1119-1125.
9. (a) W. K. Hagmann, The many roles for fluorine in medicinal chemistry, J. Med. Chem., 2008, 51, 4359-4369;
10. (b) A. M. Thayer, Fabulous fluorine: having fluorine in life sciences molecules brings desirable benefits, but the trick is getting it in place and making sought- after building blocks, Chem. Eng. News, 2006, 84, 15-24.
11. R. Ruzziconi and F. Buonerba, J. Fluorine Chem., 2013, 152, 12-28.
12. (a) R. F. Service, 6 September 2013 Vol 341 Science http://www.sciencemag.org;
13. (b) M. D. F. Ismail, J. Fluorine Chem., 2002, 118, 27-33.
14. (a) R. D. H. Murray, J. Mendez and S. A. Brown, The Natural Coumarins: Occurrence, Chemistry, and Biochemistry, Wiley and Sons, New York, 1982;
15. (b) R. O. Kennedy and R. D. Zhorenes, Coumarins: Biology Applications and Mode of Action, John Wiley and Sons, Chichester, 1997;
16. (c) S. Sandhu, Y. Bansal, O. Silakari and G. Bansal, Bioorg. Med. Chem., 2014, 22, 3806-3814.
17. X. M. Peng, G. L. V. Damu and C. H. Zhou, Curr. Pharm. Des., 2013, 19, 3884-3930.
18. X.-Q. Wu, C. Huang, Y.-M. Jia, B.-A. Song, J. Li and X.-X. Liu, Eur. J. Med. Chem., 2014, 74, 717-725.
19. (a) C. Y. Chu, Y. Y. Tsai, C. J. Wang, W. L. Lin and T. H. Tseng, Eur. J. Pharmacol., 2001, 416, 25-32;
20. (b) M. C. Ruiz, R. R. Chilpa, E. Estrada, E. J. Reyes, G. G. Fariña and L. R. J. Fragoso, J. Pharm. Pharmacol., 2007, 59, 719-725.
21. R. C. N. Williamson, P. J. Lyndon and A. J. C. Tudway, Br. J. Cancer, 1980, 42, 85-94.
22. F. Meggio, M. A. Pagano, S. Moro, G. Zagotto, M. Ruzzene, S. Sarno, G. Cozza, J. Bain, M. Elliott, A. D. Deana, A. M. Brunati and L. A. Pinna, Biochemistry, 2004, 43, 12931-12936.
23. H. Morita, T. Dota and J. Kobayashi, Bioorg. Med. Chem. Lett., 2004, 14, 3665-3668.
24. Y. Chen, H.-R. Liu, H.-S. Liu, M. Cheng, P. Xia, K. Qian, P.-C. Wu, C.-Y. Lai, Y. Xia, Z.-Y. Yang, S. L. Morris-Natschke and K.-H. Lee, Eur. J. Med. Chem., 2012, 49, 74-85.
25. (a) G. L. Bras, C. Radanyi, J. F. Peyrat, J. D. Brion, M. Alami, V. Marsaud, B. Stella and J. M. Renoir, J. Med. Chem., 2007, 50, 6189-6200;
26. (b) A. C. Donnelly, J. R. Mays, J. A. Burlison, J. T. Nelson, G. Vielhauer, J. Holzbeierlein and B. S. J. Blagg, J. Org. Chem., 2008, 73, 8901-8920;
27. (c) H. P. Zhao, A. C. Donnelly, B. R. Kusuma, G. E. L. Brandt, D. Brown, R. A. Rajewski, G. Vielhauer, J. Holzbeierlein, M. S. Cohen and B. S. J. Blagg, J. Med. Chem., 2011, 54, 3839-3853;
28. (d) H. P. Zhao, B. Yan, L. B. Peterson and B. S. J. Blagg, ACS Med. Chem. Lett., 2012, 3, 327-331.
29. (a) Y. Dong, Q. Shi, Y.-N. Liu, X. Wang, K. F. Bastow and K.-H. Lee, J. Med. Chem., 2009, 52, 3586-3590;
30. (b) X. Wang, K. Nakagawa-Goto, K. F. Bastow, M. J. Don, Y.-L. Lin, T.-S. Wu and K.-H. Lee, J. Med. Chem., 2006, 49, 5631-5634;
31. (c) X. Wang, K. F. Bastow, C. M. Sun, Y. L. Lin, H. J. Yu, M. J. Don, T. S. Wu, S. Nakamura and K. H. Lee, J. Med. Chem., 2004, 47, 5816-5819.
32. S. J. Stanway, A. Purohit, L. W. Woo, S. Sufi, D. Vigushin, R. Ward, R. H. Wilson, F. Z. Stanczyk, N. Dobbs, E. Kulinskaya, M. Elliott, B. V. Potter, M. J. Reed and R. C. Coombes, Clin. Cancer Res., 2006, 12, 1585-1592.
33. X. Xu, Y. Zhang, D. Qu, T. Jiang and S. Li, J. Exp. Clin. Cancer Res., 2011, 30, 30-33.
34. W. Zhang, Z. Li, M. Zhou, F. Wu, X. Hou, H. Luo, H. Liu, X. Han, G. Yan, Z. Ding and R. Li, Bioorg. Med. Chem. Lett., 2014, 24, 799-807.
35. (a) V. V. Iyer, G. W. Griesgraber, M. R. Radmer, E. J. McIntee and C. R. Wagner, J. Med. Chem., 2000, 43, 2266-2274;
36. (b) F. Focher, D. Ubiali, M. Pregnolato, C. Zhi, J. Gambino, G. E. Wright and S. Spadari, J. Med. Chem., 2000, 43, 2601-2607;
37. (c) S. A. Rostom, H. M. Ashour and H. A. Abdel Razik, Arch. Pharm., 2009, 342, 299-310;
38. (d) N. R. Lomax and V. L. Narayanan, Chemical Structures of Interest to the Division of Cancer Treatment, developmental Therapeutics Program, National Cancer Institute, Bethesda, MD, 1988, vol. 4, p. 32;
39. (e) R. Griffith and T. Tracy, in Foye's Principles of Medicinal Chemistry, ed. D. A. Williams and T. L. Lemke, Fifth edn, Lippincott Williams and Wilkins, 2002, p. 900.
40. E. D. Clercq, J. Clin. Virol., 2004, 30, 115-133.
41. D. A. Aboul El-Ella, M. M. Ghorab, E. Noaman, H. I. Heiba and A. I. Khalil, Bioorg. Med. Chem., 2008, 16, 2391-2402.
42. J. E. Gready, C. McKinlay and M. G. Gebauer, Eur. J. Med. Chem., 2003, 38, 719-728.
43. (a) R. S. Keri, K. M. Hosamani, R. V. Shingalapur and M. H. Hugar, Eur. J. Med. Chem., 2010, 45, 2597-2605;
44. (b) J. K. Gupta, P. K. Sharma, R. Dudhe, A. Chaudhary, A. Singh, P. K. Verma, S. C. Mondal, R. K. Yadav and S. Kashyap, Med. Chem. Res., 2012, 21, 1625-1632.
45. F. Zahran, I. M. EL-Deen, M. M. El-behary and A. T. Keshta, Int. J. Appl. Basic Med. Res., 2013, 3, 481-485.
46. K. B. Puttaraju, K. Shivashankar, Chandra, M. Mahendra, V. P. Rasal, P. N. V. Vivek, K. Rai and M. B. Chanu, Eur. J. Med. Chem., 2013, 69, 316-322.
47. I. Hyohdoh, N. Furuichi, T. Aoki, Y. Itezono, H. Shirai, S. Ozawa, F. Watanabe, M. Matsushita, M. Sakaitani, P.-S. Ho, K. Takanashi, N. Harada, Y. Tomii, K. Yoshinari, K. Ori, M. Tabo, Y. Aoki, N. Shimma and H. Iikura, ACS Med. Chem. Lett., 2013, 4, 1059-1063.
48. (a) J. Hamelin, J.-P. Bazureau and F. T. Boullet, in Microwaves in Organic Chemisry, ed. A. Loupy, Wiley-VCH, Weinheim, Germany, 2nd edn, 2003, Ch. 8, p. 253;
49. (b) A. de la Hoz, A. Diaz-Ortizand and A. Moreno, Chem. Soc. Rev., 2005, 34, 164-178;
50. (c) C. O. Kappe, Chem. Soc. Rev., 2008, 37, 1127;
51. (d) R. Sarma and D. Prajapati, Green Chem., 2011, 13, 718-722.
52. (a) B. L. Hayes, Aldrichimica Acta, 2004, 37 (2), 66-76;
53. (b) D. Bogdal, Microwave assisted Organic Synthesis, Elsevier Publications, UK, 2005, p. 13.
54. (a) V. Santagada, F. Frecentese, E. Perissutti, F. Fiorino, B. Severino and G. Caliendo, Mini-Rev. Med. Chem., 2009, 9, 340-358;
55. (b) M. Nüchter, B. Ondruschka, W. Bonrath and A. Gum, Green Chem., 2004, 6, 128-141;
56. (c) C. O. Kappe, B. Pieber and D. Dallinger, Angew. Chem., Int. Ed., 2013, 52, 1088-1094;
57. (d) K. C. Oliver and D. Doris, Nat. Rev. Drug Discovery, 2006, 5, 51-63.
58. R. S. Keri, K. M. Hosamani, H. S. Reddy and R. V. Shingalapur, Catal. Lett., 2009, 131, 552-559.
59. K. M. Hosamani, H. R. Seetharamareddy, R. S. Keri, M. S. Hanamanthagouda and M. G. Moloney, J. Enzyme Inhib. Med. Chem., 2009, 24, 1095-1100.
60. N. Kumar, S. Kumar, H. Gupta and P. K. Sharma, World Res. J. Biochem., 2012, 1, 1-5.
61. G. M. Sheldrick, SHELX97 Program for Crystallography Refinement, University of Göttingen, Germany, 1997.
62. A. Doyle and J. B. Griffiths, Cell and Tissue Culture for Medical Research, John Wiley and sons Ltd., First edn, 2000, p. 409.
63. T. A. Brown, Essential Molecular Biology: A Practical Approach, Oxford University Press., 1990, vol. 1, p. 51.
64. S. Sreelatha, P. R. Padma and M. Umadevi, Food Chem. Toxicol., 2009, 47, 702-708.
65. S. Tabassum, A. Asim, F. Arjmand, M. Afzal and V. Bagchi, Eur. J. Med. Chem., 2012, 58, 308-316.
66. V. Kumar, K. Kaur, D. N. Karelia, V. Beniwal, G. K. Gupta, A. K. Sharma and A. K. Gupta, Eur. J. Med. Chem., 2014, 81, 267-276.
67. V. K. Singh, R. Kadu and H. Roy, Eur. J. Med. Chem., 2014, 74, 552-561.